The PE Ratio as of November 2024 (TTM) for Angion Biomedica Corp. (ANGN) is -0.10

According to Angion Biomedica Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.10. This represents a change of -78.09% compared to the average of -0.45 of the last 4 quarters.

Angion Biomedica Corp. (ANGN) Historical PE Ratio (quarterly & annually)

How has ANGN PE Ratio performed in the past?

The mean historical PE Ratio of Angion Biomedica Corp. over the last ten years is 170.37. The current -0.10 PE Ratio has changed -105.81% with respect to the historical average. Over the past ten years (40 quarters), ANGN's PE Ratio was at its highest in in the March 2013 quarter at 1.39K. The PE Ratio was at its lowest in in the June 2014 quarter at -274.29.

Angion Biomedica Corp. (ANGN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Angion Biomedica Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Angion Biomedica Corp. (ANGN) Average PE Ratio

How has ANGN PE Ratio performed in the past?

The current PE Ratio of Angion Biomedica Corp. (ANGN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Angion Biomedica Corp. (ANGN) PE Ratio vs. Peers

How is ANGN’s PE Ratio compared to its peers?

Angion Biomedica Corp.’s PE Ratio is less than eFFECTOR Therapeutics, Inc. (-0.00), greater than Landos Biopharma, Inc. (-5.74), greater than Apexigen, Inc. (-0.24), less than Navidea Biopharmaceuticals, Inc. (0.03), less than Oncorus, Inc. (-0.04), greater than Apollomics, Inc. (-0.15), greater than Sigilon Therapeutics, Inc. (-16.76), greater than Pyxis Oncology, Inc. (-2.01), greater than Zura Bio Limited (-5.60), less than Altamira Therapeutics Ltd. (-0.03), greater than Elevation Oncology, Inc. (-0.85), less than ZyVersa Therapeutics, Inc. (-0.00), greater than Palisade Bio, Inc. (-0.26), greater than Unicycive Therapeutics, Inc. (-1.63), greater than Immix Biopharma, Inc. (-2.41),

Build a custom stock screener for Angion Biomedica Corp. (ANGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Angion Biomedica Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Angion Biomedica Corp. (ANGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Angion Biomedica Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.